Antoine Francis: Building the Future of Plasma Supply with Quality, Traceability, and Purpose
Antoine Francis shared a post from Global Plasma Supply on LinkedIn:
“At Global Plasma Supply, we don’t just operate—we stand.
On three pillars engraved into every decision we make:
Quality. Traceability. Purpose.
These aren’t taglines. They are non-negotiables.
They are the foundation for how we collect, protect, and transform plasma into life-saving therapies—ethically and globally.
From donor to vial, from first touch to final dose, our systems ensure:
- Nothing is lost.
- No life is compromised.
- Every drop fulfills its calling.
In a world where regulatory shadows still linger and untraceable plasma slips into questionable circuits, we don’t flinch.
We draw the line.
Only trusted, traceable, purpose-bound plasma has a place in the future of healthcare.
And at GPS—we build that future, drop by drop.”
Read the full article here:
Stay informed on the emerging news in Hematology with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS